Navigation Links
Orexigen® Therapeutics' Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
Date:12/7/2010

SAN DIEGO and OSAKA, Japan, Dec. 7, 2010 /PRNewswire-FirstCall/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) and Takeda Pharmaceutical Company Limited (Takeda) (TSE:4502) announced today that the U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 13 to 7 that the available data adequately demonstrate that the potential benefits of Contrave® (naltrexone sustained release (SR)/bupropion SR) outweigh the potential risks when used long-term in a population of overweight and obese individuals and support approval. The Committee also voted 11 to 8 that a dedicated study to examine the drug's effect on risk for major adverse cardiac events should be conducted as a post-approval requirement versus pre-approval.

"We are encouraged by the panel's view of the risk-benefit profile of Contrave," said Michael Narachi, president and CEO of Orexigen.  "We look forward to continued discussions with the FDA regarding the design of a post-marketing study to evaluate cardiovascular risk and to address the questions raised at the meeting today in preparation for our PDUFA action date in January."

The advisory committee's decision is a non-binding recommendation to be considered by the FDA in finalizing the review of the Contrave New Drug Application (NDA).  A PDUFA action date of January 31, 2011 has been assigned for the review of the NDA.

"We are pleased with today's committee vote, an important step on the path to approval for this potential new option for the treatment of obesity and an example of the dedication of the Orexigen-Takeda team," said Shinji Honda, president and CEO of Takeda Pharmaceuticals North America, Inc., a wholly-owned subsidiary of Takeda.  "Takeda is committed to working to provide new treatment options in managing obesity and helping physicians address this growing epidemic. 
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
2. Orexigen® Therapeutics to Speak at Fifth Annual JMP Securities Healthcare Conference
3. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
4. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
5. Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
6. Orexigen® Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet
7. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
8. Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity
9. Nile Therapeutics Receives NASDAQ Notice; Will Request Hearing
10. Halozyme Therapeutics Realigns Management
11. Cell Therapeutics Files Appeal on FDA Decision on New Drug Application (NDA) for Pixantrone to Treat Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... MINNEAPOLIS, Jan. 22, 2015  Uroplasty, Inc. (NASDAQ: UPI ... markets innovative proprietary products to treat voiding dysfunctions, today ... ended December 31, 2014.  Global revenue for the ... $4.4 million, a new quarterly revenue record, as compared ...
(Date:1/22/2015)... , Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; ... a focus on Omega-3 therapies for cardiovascular disease and overall ... the Company,s accomplishments in 2014 and its outlook for 2015 ... Dear Fellow Shareholders, We would like to take ...
(Date:1/22/2015)... MINNEAPOLIS , Jan. 22, 2015  Bio-Techne Corporation (NASDAQ: ... launched Ella, the first member of the new Simple ... ProteinSimple brand.  This launch represents the re-branding of the ... The Simple Plex platform is a transformative immunoassay technology ...
Breaking Medicine Technology:Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3
... Sept. 24 Cancer treatment specialists,reported yesterday ... provide,faster, more accurate cancer treatments than was ... presentations given at an,"Emerging Technologies" Symposium sponsored ... in connection with the annual meeting of ...
... Ltd,(TASE: BIOV) from Rehovot, Israel, reported today results of its ... detection of lung cancer., In the trial a total ... 1. Healthy individuals that never smoked 2. ... Early stage lung cancer patients (Stage 1) 4. Advanced ...
Cached Medicine Technology:Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients 2Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients 3Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients 4BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test 2
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David ... Show to bestow a Juvent Sports Achievement award upon ... McKitrick. The award commemorated and congratulated McKitrick for her ... won her first amateur tournament in 1979 and most ...
(Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
(Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
(Date:1/22/2015)... DC (PRWEB) January 22, 2015 Payday ... in vulnerable communities and cause financial distress to the ... by analysts at Howard University’s Center on Race and ... dollars in economic activity, payday loans at the same ...
(Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting a ... insurance policy . , Some types of vehicles cannot be ... newly released blog post to see if their vehicle qualifies for ... are some of the cars that cannot be covered by a ...
Breaking Medicine News(10 mins):Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... Progressives Look to Obama Plan as Down Payment on ... more people filing for unemployment than at any time ... crisis since the Great Depression, Campaign for America,s Future ... deliver President Obama ,s electoral victory to rally ...
... Blue Cross and Blue Shield of,Florida, Inc. (BCBSF) ... and Pinellas Counties to offer BlueSelect(R), a new ... This affordable option features a,community based network, allowing ... percent,on services and premiums, without sacrificing quality coverage. ...
... DOWN; CALL OUT FOR BLOOD DONORSWASHINGTON, Jan. 28 The ... people overnight whose homes were without power from the winter ... of the country. According to news reports, the storm has ... moves into the Northeast, bringing with it additional warnings of ...
... New Digest: , , Summary of study ... Journal of Clinical Oncology ,showing no survival ... whose ovaries were left intact during cancer surgery ... Quote for attribution from Beth Karlan, MD, American ...
... 2009Omega-3s ease psychological distress and depressive symptoms often ... researchers at Universit Laval,s Faculty of Medicine. Their ... American Journal of Clinical Nutrition , presents ... for treating common menopause-related mental health problems. , ...
... computers by means of metal electrodes, in the hope of ... healing conditions such as blindness or epilepsy. In the future, ... on nerve cells grown for that purpose. In research that ... , Prof. Elisha Moses of the Physics of Complex Systems ...
Cached Medicine News:Health News:Blue Cross and Blue Shield of Florida Partners with Community Providers to Offer Low-Cost 'BlueSelect' Health Plan for Hillsborough and Pinellas Counties 2Health News:Red Cross Offers Warmth, Shelter as Storm Cuts Power Across the Country 2Health News:Red Cross Offers Warmth, Shelter as Storm Cuts Power Across the Country 3Health News:Study shows younger women with endometrial cancer can safely keep ovaries, avoid early menopause 2Health News:Omega-3s ease depressive symptoms related to menopause 2Health News:Weizmann Institute scientists create working artificial nerve networks 2
Available in 10 beautiful opaque colors....
An entirely new way to brighten and enhance natural eye color....
Disposable-type color lenses for exciting eye color change....
... The world standard in corneal ... like endothelium, descemet's membrane, stroma, Bowman's ... of Corneal Components. Broad Applications in ... pachymetry, post-surgery interface evaluation, endothelial cell ...
Medicine Products: